Search

#LungCancer
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 15h

A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as late diagnoses, access issues, stigma, and a lack of oncologist consultations, despite the availability of promising new therapies that have significantly improved treatment outcomes for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US #CO #TX

www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
New drugs have made America's deadliest cancer more treatable than ever. So why aren't they reaching patients. More than half of patients with metastatic lung cancer don't receive life-extending treatments, like chemotherapy, immunotherapy and targeted therapy, a new study found.
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 16h

A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, such as chemotherapy and immunotherapy, due to barriers like late diagnosis, access issues, shame, and fatalism, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US

www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
New drugs have made America's deadliest cancer more treatable than ever. So why aren't they reaching patients. More than half of patients with metastatic lung cancer don't receive life-extending treatments, like chemotherapy, immunotherapy and targeted therapy, a new study found.
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 17h

A study published in JAMA Oncology reveals that more than half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as diagnostic delays, lack of access to oncologists, and social stigma, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US

www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
New drugs have made America's deadliest cancer more treatable than ever. So why aren't they reaching patients. More than half of patients with metastatic lung cancer don't receive life-extending treatments, like chemotherapy, immunotherapy and targeted therapy, a new study found.
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 18h

A recent study revealed that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, highlighting barriers such as access, stigma, and diagnostic delays, despite significant advancements in drug options that have made the disease more treatable. #LungCancer #CancerTreatment #HealthEquity #US #TX

www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
New drugs have made America's deadliest cancer more treatable than ever. So why aren't they reaching patients. More than half of patients with metastatic lung cancer don't receive life-extending treatments, like chemotherapy, immunotherapy and targeted therapy, a new study found.
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 19h

A recent study published in JAMA Oncology revealed that over half of patients with metastatic lung cancer, despite the availability of new, effective treatments, do not receive life-extending therapies due to various barriers such as access issues, late diagnoses, stigma, and lack of oncologist consultations, highlighting a significant gap in care for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US

www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
New drugs have made America's deadliest cancer more treatable than ever. So why aren't they reaching patients. More than half of patients with metastatic lung cancer don't receive life-extending treatments, like chemotherapy, immunotherapy and targeted therapy, a new study found.
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 20h

A recent study highlights that despite advancements in treatments for metastatic lung cancer, over half of patients do not receive life-extending therapies due to various barriers such as access issues, misconceptions about the disease, and the stigma associated with smoking, emphasizing the need for improved patient access to oncologists and education about available treatments. #LungCancer #CancerTreatment #HealthCareAccess #US

www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
New drugs have made America's deadliest cancer more treatable than ever. So why aren't they reaching patients. More than half of patients with metastatic lung cancer don't receive life-extending treatments, like chemotherapy, immunotherapy and targeted therapy, a new study found.